Overexpression of the C-terminal PG-M/versican domain impairs growth of tumor cells by intervening in the interaction between epidermal growth factor receptor and _@b1-integrin

Journal of Cell Science

Volumn 117, Issue 11, 2004, Pages 2227-2237

  Wu, Yaojiong ^a   Chen, Liwen ^a   Cao, Liu ^a   Sheng, Wang ^a   Yang, Burton B ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cell cycle; EGFR; G3 domain; Immunoprecipitation; Interaction; Phosphorylation

Indexed keywords

BETA1 INTEGRIN; EPIDERMAL GROWTH FACTOR RECEPTOR; FOCAL ADHESION KINASE; MUTANT PROTEIN; VERSICAN;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; ASTROCYTOMA; CANCER INHIBITION; CARCINOGENESIS; CELL ADHESION; CELL GROWTH; CELL MIGRATION; CELL SPREADING; CELL SURVIVAL; CELL TRANSFORMATION; COMPLEX FORMATION; CONTROLLED STUDY; DISSOCIATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; SERUM; SIGNAL TRANSDUCTION;

ANTIGENS, CD29; APOPTOSIS; CELL ADHESION; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CULTURE MEDIA, SERUM-FREE; EPIDERMAL GROWTH FACTOR; FOCAL ADHESION KINASE 1; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; LECTINS, C-TYPE; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN-TYROSINE KINASES; PROTEOCHONDROITIN SULFATES; RECEPTOR, EPIDERMAL GROWTH FACTOR; SEQUENCE DELETION; TRANSFECTION; TUMOR STEM CELL ASSAY; VERSICANS;

ANIMALIA;

EID: 3042646119     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.01057     Document Type: Article

References (44)

1. Ang, L. C., Zhang, Y., Can, L., Yang, B. L., Young, B., Kiani, C., Lee, V., Allan, K. and Yang, B. B. (1999). Versican enhances locomotion of astrocytoma cells and reduces cell adhesion through its G1 domain. J. Neuropathol. Exp. Neurol. 58, 597-605.
2. Aspberg, A., Binkert, C. and Ruoslahti, E. (1995). The versican C-type lectin domain recognizes the adhesion protein tenascin-R. Proc. Natl. Acad. Sci. USA 92, 10590-10594.
3. Binette, F., Cravens, J., Kahoussi, B., Haudenschild, D. R. and Goetinck, P. F. (1994). Link protein is ubiquitously expressed in non-cartilaginous tissues where it enhances and stabilizes the interaction of proteoglycans with hyaluronic acid. J. Biol. Chem. 269, 19116-19122.
4. Bruns, C. J., Solorzano, C. C., Harbison, M. T., Ozawa, S., Tsan, R., Fan, D., Abbruzzese, J., Traxler, P., Buchdunger, E., Radinsky, R. et al. (2000). Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma. Cancer Res. 60, 2926-2935.
5. KIP1 independent of MAPK activity. J. Biol. Chem. 275, 6987-6995.
6. Cao, L., Yao, Y., Lee, V., Kiani, C., Spaner, D., Lin, Z., Zhang, Y., Adams, M. E. and Yang, B. B. (2000). Epidermal growth factor induces cell cycle arrest and apoptosis of squamous carcinoma cells through reduction of cell adhesion. J. Cell Biochem. 77, 569-583.
7. Cattaruzza, S., Schiappacassi, M., Ljungberg-Rose, A., Spessotto, P., Perissinotto, D., Morgelin, M., Mucignat, M. T., Colombatti, A. and Perris, R. (2002). Distribution of PG-M/versican variants in human tissues and de novo expression of isoform V3 upon endothelial cell activation, migration, and neoangiogenesis in vitro. J. Biol. Chem. 277, 47626-47635.
8. Chen, L., Yang, B. L., Wu, Y., Yee, A. and Yang, B. B. (2003). G3 domains of aggrecan and PG-M/versican form intermolecular disulfide bonds that stabilize cell-matrix interaction. Biochemistry 42, 8332-8341.
9. Condic, M. L. and Letourneau, P. C. (1997). Ligand-induced changes in integrin expression regulate neuronal adhesion and neurite outgrowth. Nature 389, 852-856.
10. Couzin, J. (2001). Cell biology. Integrin crystal structure solved. Science 293, 1743-1746.
11. Guadagno, T. M., Ohtsubo, M., Roberts, J. M. and Assoian, R. K. (1993). A link between cyclin A expression and adhesion-dependent cell cycle progression. Science 262, 1572-1575.
12. Isogai, Z., Aspberg, A., Keene, D. R., Ono, R. N., Reinhardt, D. P. and Sakai, L. Y. (2002). Versican interacts with fibrillin-1 and links extracellular microfibrils to other connective tissue networks. J. Biol. Chem. 277, 4565-4572.
13. Ito, K., Shinomura, T., Zako, M., Ujita, M. and Kimata, K. (1995). Multiple forms of mouse PG-M, a large chondroitin sulfate proteoglycan generated by alternative splicing. J. Biol. Chem. 270, 958-965.
14. Kawashima, H., Hirose, M., Hirose, J., Nagakubo, D., Plaas, A. H. and Miyasaka, M. (2000). Binding of a large chondroitin sulfate/dermatan sulfate proteoglycan, versican, to L-selectin, P-selectin, and CD44. J. Biol. Chem. 275, 35448-35456.
15. Kiani, C., Chen, L., Lee, V., Zheng, P. S., Wu, Y., Wen, J., Cao, L., Adams, M. E., Sheng, W. and Yang, B. B. (2003). Identification of the motifs and amino acids in aggrecan G1 and G2 domains involved in product secretion. Biochemistry 42, 7226-7237.
16. Kornberg, L., Earp, H. S., Parsons, J. T., Schaller, M. and Juliano, R. L. (1992). Cell adhesion or integrin clustering increases phosphorylation of a focal adhesion-associated tyrosine kinase. J. Biol. Chem. 267, 23439-23442.
17. LeBaron, R. G., Zimmermann, D. R. and Ruoslahti, E. (1992). Hyaluronate binding properties of versican. J. Biol. Chem. 267, 10003-10010.
18. Lemire, J. M., Braun, K. R., Maurel, P., Kaplan, E. D., Schwartz, S. M. and Wight, T. N. (1999). Versican/PG-M isoforms in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 19, 1630-1639.
19. Lu, Z., Jiang, G., Blume-Jensen, P. and Hunter, T. (2001). Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase. Mol. Cell. Biol. 21, 4016-4031.
20. Matsumoto, K., Shionyu, M., Go. M., Shimizu, K., Shinomura, T., Kimata, K. and Watanabe, H. (2003). Distinct interaction of versican/PG-M with hyaluronan and link protein. J. Biol. Chem. 278, 41205-41212.
21. Moro, L., Venturino, M., Bozzo, C., Silengo, L., Altruda, F., Beguinot, L., Tarone, G. and Defilippi, P. (1998). Integrins induce activation of EGF receptor: role in MAP kinase induction and adhesion-dependent cell survival. EMBO J. 17, 6622-6632.
22. Nara, Y., Kato, Y., Torii, Y., Tsuji, Y., Nakagaki, S., Goto, S., Isobe, H., Nakashima, N. and Takeuchi, J. (1997). Immunohistochemical localization of extracellular matrix components in human breast tumours with special reference to PG-M/versican. Histochem. J. 29, 21-30.
23. Olin, A. I., Morgelin, M., Sasaki, T., Timpl, R., Heinegard, D. and Aspberg, A. (2001). The proteoglycans aggrecan and versican form networks with fibulin-2 through their lectin domain binding. J. Biol. Chem. 276, 1253-1261.
24. Paulus, W., Baur, I., Dours-Zimmermann, M. T. and Zimmermann, D. R. (1996). Differential expression of versican isoforms in brain tumors. J. Neuropathol. Exp. Neurol. 55, 528-533.
25. Prendergast, G. C. (1999). Mechanisms of apoptosis by c-Myc. Oncogene 18, 2967-2987.
26. Schenk, S., Hintermann, E., Bilban, M., Koshikawa, N., Hojilla, C., Khokha, R. and Quaranta, V. (2003). Binding to EGF receptor of a laminin-5 EGF-like fragment liberated during MMP-dependent mammary gland involution. J. Cell Biol. 161, 197-209.
27. Shinomura, T., Nishida, Y., Ito, K. and Kimata, K. (1993). cDNA cloning of PG-M, a large chondroitin sulfate proteoglycan expressed during chondrogenesis in chick limb buds. Alternative spliced multiforms of PGM and their relationships to versican. J. Biol. Chem. 268, 14461-14469.
28. St Croix, B. and Kerbel, R. S. (1997). Cell adhesion and drug resistance in cancer. Curr. Opin. Oncol. 9, 549-556.
29. Swindle, C. S., Tran, K. T., Johnson, T. D., Banerjee, P., Mayes, A. M., Griffith, L. and Wells, A. (2001). Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor. J. Cell Biol. 154, 459-468.
30. Wu, Y., Chen, L., Zheng, P. S. and Yang, B. B. (2002). Beta 1-integrin-mediated glioma cell adhesion and free radical-induced apoptosis are regulated by binding to a C-terminal domain of PG-M/versican. J. Biol. Chem. 277, 12294-12301.
31. Wu, Y., Zhang, Y., Cao, L., Chen, L., Lee, V., Zheng, P. S., Kiani, C., Adams, M. E., Ang, L. C., Paiwand, F. and Yang, B. B. (2001). Identification of the motif in versican G3 domain that plays a dominant-negative effect on astrocytoma cell proliferation through inhibiting versican secretion and binding. J. Biol. Chem. 276, 14178-14186.
32. Yamada, K. M. and Even-Ram, S. (2002). Integrin regulation of growth factor receptors. Nat. Cell Biol. 4, E75-E76.
33. Yamagata, M., Yamada, K. M., Yoneda, M., Suzuki, S. and Kimata, K. (1986). Chondroitin sulfate proteoglycan (PG-M-like proteoglycan) is involved in the binding of hyaluronic acid to cellular fibronectin. J. Biol. Chem. 261, 13526-13535.
34. Yang, B. L., Cao, L., Kiani, C., Lee, V., Zhang, Y., Adams, M. E. and Yang, B. B. (2000). Tandem repeats are involved in G1 domain inhibition of versican expression and secretion and the G3 domain enhances glycosaminoglycan modification and product secretion via the complement-binding protein-like motif. J. Biol. Chem. 275, 21255-21261.
35. Yang, B. L., Yang, B. B., Erwin, M., Ang, L. C., Finkelstein, J. and Yee, A. J. (2003). Versican G3 domain enhances cellular adhesion and proliferation of bovine intervertebral disc cells cultured in vitro. Life. Sci. 73, 3399-3413.
36. Yang, B. L., Zhang, Y., Cao, L. and Yang, B. B. (1999). Cell adhesion and proliferation mediated through the G1 domain of versican. J. Cell Biochem. 72, 210-220.
37. Yokosaki, Y., Matsuura, N., Higashiyama, S., Murakami, I., Obara, M., Yamakido, M., Shigeto, N., Chen, J. and Sheppard, D. (1998). Identification of the ligand binding site for the integfin alpha9 beta1 in the third fibronectin type III repeat of tenascin-C. J. Biol. Chem. 273, 11423-11428.
38. Zhang, Y., Cao, L., Kiani, C., Yang, B. L., Hu, W. and Yang, B. B. (1999). Promotion of chondrocyte proliferation by versican mediated by G1 domain and EGF-like motifs. J. Cell Biochem. 73, 445-457.
39. Zhang, Y., Cao, L., Kiani, C. G., Yang, B. L. and Yang, B. B. (1998a). The G3 domain of versican inhibits mesenchymal chondrogenesis via the epidermal growth factor-like motifs. J. Biol. Chem. 273, 33054-33063.
40. Zhang, Y., Cao, L., Yang, B. L. and Yang, B. B. (1998b). The G3 domain of versican enhances cell proliferation via epidermial [sic] growth factor-like motifs. J. Biol. Chem. 273, 21342-21351.
41. Zhang, Y., Wu, Y., Cao, L., Lee, V., Chen, L., Lin, Z., Kiani, C., Adams, M. E. and Yang, B. B. (2001). Versican modulates embryonic chondrocyte morphology via the epidermal growth factor-like motifs in G3. Exp. Cell Res. 263, 33-42.
42. Zheng, P. S., Wen, J. P., Ang, L. C., Sheng, W., Viloria-Petit, A., Wang, Y., Wu, Y., Kerbel, R. S. and Yang, B. B. (2004). Versican/PG-M G3 domain promotes tumor growth and angiogenesis. FASEB. J. 18, 754-756.
43. Zimmermann, D. R., Dours-Zimmermann, M. T., Schubert, M. and Bruckner-Tuderman, L. (1994). Versican is expressed in the proliferating zone in the epidermis and in association with the elastic network of the dermis. J. Cell. Biol. 124, 817-825.
44. Zimmermann, D. R. and Ruoslahti, E. (1989). Multiple domains of the large fibroblast proteoglycan, versican. EMBO J. 8, 2975-2981.